Moreover, in a further study, we demonstrated, by obtaining liver and stomach specimens for characterization of NAFLD and Hp-I, respectively, that Hp(+) bariatric patients were characterized by higher MetS components (including HOMA–IR, arterial hypertension, and dyslipidemia) than the negative ones [14]. This evidence concerns the gene HP and metabolic dysfunction-associated steatotic liver disease.